Literature DB >> 19773723

Stem cells in acute kidney injury repair.

F Tögel1, C Westenfelder.   

Abstract

New discoveries and developments in the biology and propagation of stem cells have fueled a whole new field of Medicine that has sparked great interest in the scientific community as well as in the general media and public. Stem cells are a very prominent and debated topic and have given ground to a new field of therapy in Medicine, which is called Regenerative Medicine. The kidney is a highly sophisticated and complicated organ, yet stem cell therapies have become of interest to Nephrologists and promising animal data are available showing the use of different stem cell populations in Nephrology. Acute kidney injury (AKI) is a clinical entity caused by a variety of factors resulting in renal damage and loss of function. Although it is reversible up to a point, it contributes tremendously to hospital morbidity and mortality. At the current time there are only supportive treatments available. Stem cell based therapies have the potential to become a broader and diverse treatment approach that is tailored to the pathophysiology of the disease and is therefore potentially more effective than traditional pharmacological approaches. The current article gives an overview about the field in general as well as potential treatment approaches and mechanisms.

Entities:  

Mesh:

Year:  2009        PMID: 19773723

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  2 in total

1.  The use of mesenchymal stem cells in bladder augmentation.

Authors:  Mila Torii Corrêa Leite; Luiz G Freitas-Filho; Andréia Silva Oliveira; Patrícia Semedo-Kuriki; Marcus Laks; Victor Eduardo Arrua Arias; Pedro S Peixoto
Journal:  Pediatr Surg Int       Date:  2014-04       Impact factor: 1.827

Review 2.  Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).

Authors:  Darwin J Prockop; Daniel J Kota; Nikolay Bazhanov; Roxanne L Reger
Journal:  J Cell Mol Med       Date:  2010-09       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.